INS and Glucose intolerance: Altogether, these findings suggest that, despite not showing improvement over surrogate markers of fasting insulin sensitivity such as Met, both Cg and Ec treatments are capable of regulating glucose homeostasis through the improvement of insulin function and/or glucose intolerance, as well as GSIS restoration.